Prepare Yourself for Liftoff: Pacific Biosciences of California Inc (PACB)
With 8.58 million shares changed hands, the volume of the stock remained lighter than its average volume of 10.2 million shares. The 52-week range on PACB shows that it touched its highest point at $2.72 and its lowest point at $1.06 during that stretch. It currently has a 1-year price target of $2.00. Beta for […]
There is no doubt that Pacific Biosciences of California Inc (PACB) ticks all the boxes.
With 6.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 10.31 million shares. The 52-week range on PACB shows that it touched its highest point at $2.72 and its lowest point at $1.06 during that stretch. It currently has a 1-year price target of $2.05. Beta for […]
A better buy-in window may exist right now for Pacific Biosciences of California Inc (PACB)
With 4.35 million shares changed hands, the volume of the stock remained lighter than its average volume of 10.64 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.14 whereas the lowest price it dropped to was $1.1. The 52-week range on PACB […]
Top investors say Pacific Biosciences of California Inc (PACB) ticks everything they need
With 4.83 million shares changed hands, the volume of the stock remained lighter than its average volume of 11.32 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.35 whereas the lowest price it dropped to was $1.25. The 52-week range on PACB […]
Top investors say Pacific Biosciences of California Inc (PACB) ticks everything they need
With 11.81 million shares changed hands, the volume of the stock remained heavier than its average volume of 11.34 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.385 whereas the lowest price it dropped to was $1.15. The 52-week range on PACB […]
A new trading data show Pacific Biosciences of California Inc (PACB) is showing positive returns.
With 5.77 million shares changed hands, the volume of the stock remained lighter than its average volume of 11.37 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.22 whereas the lowest price it dropped to was $1.12. The 52-week range on PACB […]
How does Pacific Biosciences of California Inc (PACB) change from a tortoise to a hare?
With 7.44 million shares changed hands, the volume of the stock remained lighter than its average volume of 11.15 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.3 whereas the lowest price it dropped to was $1.22. The 52-week range on PACB […]
Does Pacific Biosciences of California Inc (PACB) offer a good opportunity for investors?
With 6.13 million shares changed hands, the volume of the stock remained lighter than its average volume of 11.32 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $1.24 whereas the lowest price it dropped to was $1.18. The 52-week range on PACB […]
What is Pacific Biosciences of California Inc (PACB) Stock Return on Shareholders’ Capital?
With 7.28 million shares changed hands, the volume of the stock remained lighter than its average volume of 11.25 million shares. The 52-week range on PACB shows that it touched its highest point at $4.57 and its lowest point at $1.16 during that stretch. It currently has a 1-year price target of $2.54. Beta for […]
Views of Wall Street’s Leading Experts on Pacific Biosciences of California Inc
With 11.05 million shares changed hands, the volume of the stock remained lighter than its average volume of 11.22 million shares. The 52-week range on PACB shows that it touched its highest point at $6.09 and its lowest point at $1.16 during that stretch. It currently has a 1-year price target of $2.54. Beta for […]
